ARCHIVES

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

This article is from The Cancer Letter archive.

Vol. 38 No. 36 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Trimodality Therapy Improves Survival In Early Disease

January 27, 2006

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

November 23, 1979

Society Recognizes Community Oncologists (8-page issue).

June 6, 2003

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

Researchers Find Two Types Of MCL Drug Resistance

August 29, 2014